Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

BACKGROUND: Despite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the data that underpin it. OBJECTIVES: The objectives of the study were to systematically collate publishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Ira, Petersel, Danielle, Shane, Lesley G., Ng, Chee-Keng, Kirchhoff, Carol, Finch, Gregory, Lula, Sadiq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126212/
https://www.ncbi.nlm.nih.gov/pubmed/27807766
http://dx.doi.org/10.1007/s40259-016-0199-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126212/
https://www.ncbi.nlm.nih.gov/pubmed/27807766
http://dx.doi.org/10.1007/s40259-016-0199-9

Ejemplares similares